4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-008819
CVP, Critical Care sold 5,000 shares at $76.00 ($380,000)
- CVP, Critical Care acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Szyman Catherine M. · CVP, Critical Care
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $36.75 | $183,750 | 39,813.57 | D |
| 2023-09-08 | Sale : show line 2 in the form 10b5-1 | −5,000 | $76.00 | $380,000 | 34,813.57 | D |
| Open-market sales · 5,000 sh · avg $76.00 · $380,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-09-08 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −5,000 | $36.75 | 2024-05-10 | 5,000 | 52,000 | D |
Loading xslF345X05/doc4.xml…